This month, Jack and Shobita talk about the role of government in both funding and regulating innovation, as well as the politics of vaccine approval as European governments suspended distribution of the AstraZeneca vaccine. And we speak with David Goldston, currently director of MIT's Washington office, who has extensive experience in science and technology policy including on Capitol Hill and at the National Resources Defense Council. He was also a former columnist at Nature.